This article provides an overview of cell culture media, suspension models, and monitoring technologies that can maintain the quality and pluripotency of iPSC during induction, expansion, and production.

With the continuous development of technology, stem cells will surely trigger a medical revolution and become the third treatment method after drugs and surgery.

As a new pharmaceutical product, stem cell drugs are expected to make huge contributions to the pharmaceutical and medical industries in the near future.

New research demonstrates the great promise of iMSCs and iMSCs-EVs as alternative sources of MSC-derived therapies because of their powerful immunomodulatory and regenerative properties.

From January 1 to September 30, 2024, a total of 20 items were approved to acquiesce in clinical trials (implied approval for clinical trials), of which 17 items were derived from mesenchymal stem cells.

As a new frontier of medicine, cell and gene therapy is showing great potential and development momentum. Especially in the treatment of refractory diseases, more and more clinical trials of cell and gene therapy are being opened.

China has made major breakthroughs in gene therapy technology and is expected to provide accessibility and curative drugs for patients with serious diseases.

With the development of regenerative medicine, cell therapies represented by stem cells have broad application prospects in the field of anti-aging, helping to delay aging, fight aging-related diseases, and enhance the body's immunity.